Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 metabolic agent study (Eli Lilly Japan)
jRCT2080225296Phase 2Recruiting
- Sponsor
- Eli Lilly and Company
- Start
- Jul 2020
01
Overview
Phase 2 trial, sponsored by Eli Lilly and Company. Started Jul 2020; status: recruiting.
Beyond the preview
Go deeper on jRCT2080225296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080225296.